Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation
Gianluca Santise 1,
Giuseppe D'Ancona 1*,
Calogero Falletta 2,
Francesco Pirone 1,
Sergio Sciacca 1,
Marco Turrisi 1,
Domenico Biondo 3,
Michele Pilato 1
1 ISMETT-Department of Cardiac Surgery, Palermo, Italy
2 ISMETT-Department of Cardiology, Palermo, Italy
3 SMETT-Office of Research and Biomedical Sciences, Palermo, Italy
* To whom correspondence should be addressed. E-mail: rgea{at}hotmail.com.
 |
Abstract |
|---|
The aim of this study was to test the impact of donor and recipient characteristics on the development of primary graft failure (PGF) after heart transplantation (HT) by focusing on the donor's inotropic support. Heart donors and matched recipients data were prospectively collected. Univariate and multivariate analyses were used to determine independent predictors for PGF and peri-operative mortality. The donor's high inotrope requirement was defined as sustained need for dopamine exceeding 10 mg/kg/min and/or alpha agonists exceeding 0.06 mg/kg/min. PGF instead was defined as need for immediate post-HT mechanical circulatory support. Since 2006, we have performed 37 HTs. PGF occurred in six patients (16.2%). Although four patients (66.6%) were weaned off circulatory support, two of them (33.3%) died on mechanical assistance. Total in-hospital mortality was 10.8% (4/37). Upon multivariate analysis, pre-harvesting donor high inotrope dosage was the major determinant for PGF (P=0.03, OR=10.8). Given the organ shortage, many centers accepted marginal hearts assuming the donor's pre-harvest hemodynamic managing has a reduced impact on PGF development. As PGF remains the most lethal postoperative complication, the hazards should be carefully considered when using pre-harvesting high inotrope infusion rates. Keywords: Primary graft failure; Heart transplant
